CBIZ REPORTS FOURTH-QUARTER AND FULL-YEAR 2022 RESULTS
CBIZ, a leading provider of financial, insurance, and advisory services, reported robust financial performance for Q4 and the full year ending December 31, 2022. Total revenue surged by 21.5% in Q4 to $295.0 million, and by 27.8% for the full year to $1,412.0 million. Same-unit revenue rose by 10.1% for Q4 and 10.9% for the year. GAAP EPS increased 52.3% to $2.01, with projected revenue growth of 8% to 10% and GAAP EPS growth of 15% to 17% for 2023. Notably, the company repurchased 2.8 million shares and has a strong balance sheet with $319.9 million in unused borrowing capacity.
- Total revenue increased by 21.5% in Q4 and 27.8% for the full year.
- Same-unit revenue growth of 10.1% in Q4 and 10.9% for the year.
- GAAP EPS increased by 52.3% to $2.01.
- Company repurchased 2.8 million shares.
- Projected revenue growth of 8% to 10% and GAAP EPS growth of 15% to 17% for 2023.
- Loss from continuing operations increased to $11.5 million in Q4 from $9.6 million a year ago.
- Adjusted loss from continuing operations was $10.7 million in Q4.
FOURTH-QUARTER HIGHLIGHTS:
- TOTAL REVENUE UP
21.5% ; SAME-UNIT REVENUE UP10.1%
FULL-YEAR HIGHLIGHTS:
- TOTAL REVENUE UP
27.8% ; SAME-UNIT REVENUE UP10.9% - GAAP EPS UP
52.3% ; ADJUSTED EPS UP28.3% - INCOME FROM CONTINUING OPERATIONS UP
48.6% ; ADJUSTED EBITDA UP28.1%
2023 OUTLOOK:
- TOTAL REVENUE UP
8% TO10% - GAAP EPS UP
15% TO17% ; TO$2.31 $2.36 - ADJUSTED EPS UP
11% TO13% ; TO$2.36 $2.41
For the 2022 fourth quarter, CBIZ recorded revenue of
Adjusted loss from continuing operations was
For the full year ended
Adjusted income from continuing operations was
As previously announced, in the second quarter of 2021, the Company recorded a nonrecurring settlement charge of
For the full year ended
"2022 also proved to be an important year for our strategic acquisition activity as we capitalized on a robust pipeline of opportunities, which added approximately
"As we look to 2023, we expect to continue to perform well despite the economic uncertainties ahead. With the essential and recurring nature of our core services, combined with a strong balance sheet and steady cash flow, we are well-positioned going into 2023," Grisko concluded.
2023 Outlook
- The Company expects revenue to grow within a range of
8% to10% over the prior year. - The Company expects an effective tax rate of approximately
28% . The increased rate, up from25.5% in 2022, will impact diluted earnings per share by approximately .$0.08 - The Company expects a weighted average fully diluted share count of approximately 51.0 to 51.5 million shares.
- The Company expects GAAP fully diluted earnings per share from continuing operations to grow within a range of
15% to17% , to to$2.31 per share over the$2.36 per share reported for 2022.$2.01 - The Company expects Adjusted fully diluted earnings per share from continuing operations to grow within a range of
11% to13% , to to$2.36 per share over the Adjusted earnings per share of$2.41 per share reported for 2022.$2.13
Conference Call
CBIZ will host a conference call at
About CBIZ
CBIZ is a leading provider of financial, insurance and advisory services to businesses throughout
Forward-Looking Statements
Forward-looking statements in this release are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those projected. Such risks and uncertainties include, but are not limited to, the risk that the anticipated benefits and perceived advantages of an acquisition may not be achieved; the impact of COVID-19 or governmental rules related to public health issues on the Company's business, operations and clients; the Company's ability to adequately manage and sustain its growth; the Company's dependence on the trend of outsourcing business services; the Company's dependence on the services of its CEO, other key employees, producers and service personnel; the effects of any potential cyber-attacks; competitive pricing pressures; general business and economic conditions; and changes in governmental laws or regulation affecting the Company's clients, business, business services operations, or business models. A more detailed description of such risks and uncertainties may be found in the Company's filings with the
| ||||||||
Three Months Ended | ||||||||
2022 | % | 2021 | % | |||||
Revenue | 100.0 % | 100.0 % | ||||||
Operating expenses (1) | 302,560 | 102.5 | 246,402 | 101.5 | ||||
Gross loss | (7,517) | (2.5) | (3,574) | (1.5) | ||||
Corporate general and administrative expenses (1) | 11,895 | 4.0 | 14,816 | 6.1 | ||||
Operating loss | (19,412) | (6.5) | (18,390) | (7.6) | ||||
Other (expense) income: | ||||||||
Interest expense | (2,830) | (0.9) | (1,016) | (0.4) | ||||
Gain (loss) on sale of operations, net | 102 | — | (390) | (0.2) | ||||
Other income, net (1) (2) | 5,694 | 1.9 | 6,212 | 2.6 | ||||
Total other income, net | 2,966 | 1.0 | 4,806 | 2.0 | ||||
Loss from continuing operations before income tax benefit | (16,446) | (5.5) | (13,584) | (5.6) | ||||
Income tax benefit | (4,953) | (3,971) | ||||||
Loss from continuing operations | (11,493) | (3.9) | (9,613) | (4.0) | ||||
Loss from operations of discontinued businesses, net of tax | (5) | (7) | ||||||
Net loss | (3.9) % | $ (9,620) | (4.0) % | |||||
Diluted loss per share: | ||||||||
Continuing operations | $ (0.23) | $ (0.19) | ||||||
Discontinued operations | — | — | ||||||
Net loss | $ (0.23) | $ (0.19) | ||||||
Diluted weighted average common shares outstanding | 50,538 | 51,899 | ||||||
Other data from continuing operations: | ||||||||
Adjusted EBITDA (3) | $ (4,351) | $ (5,021) | ||||||
Adjusted EPS (3) | $ (0.21) | $ (0.19) |
(1) | CBIZ sponsors a deferred compensation plan, under which a CBIZ employee's compensation deferral is held in a rabbi trust | ||||||||||||||||||||||
Income and expenses related to the deferred compensation plan for the three months ended | |||||||||||||||||||||||
Three Months Ended | |||||||||||||||||||||||
2022 | % of Revenue | 2021 | % of Revenue | ||||||||||||||||||||
Operating expenses | $ 5,748 | 1.9 % | $ 6,152 | 2.5 % | |||||||||||||||||||
Corporate general and administrative expenses | 926 | 0.3 % | 908 | 0.4 % | |||||||||||||||||||
Other income, net | 6,674 | 2.3 % | 7,060 | 2.9 % | |||||||||||||||||||
Excluding the impact of the above-mentioned income and expenses related to the deferred compensation plan, the operating | |||||||||||||||||||||||
Three Months Ended | |||||||||||||||||||||||
2022 | 2021 | ||||||||||||||||||||||
As | Deferred | Adjusted | % of | As | Deferred | Adjusted | % of | ||||||||||||||||
Gross (loss) margin | $ (7,517) | $ 5,748 | $ (1,769) | (0.6) % | $ (3,574) | $ 6,152 | $ 2,578 | 1.1 % | |||||||||||||||
Operating loss | (19,412) | 6,674 | (12,738) | (4.3) % | (18,390) | 7,060 | (11,330) | (4.7) % | |||||||||||||||
Other income (expense), net | 5,694 | (6,674) | (980) | (0.3) % | 6,212 | (7,060) | (848) | (0.3) % | |||||||||||||||
Loss from continuing operations before | (16,446) | — | (16,446) | (5.6) % | (13,584) | — | (13,584) | (5.6) % | |||||||||||||||
(2) | Included in "Other income, net" for the three months ended | ||||||||||||||||||||||
(3) | Refer to the financial highlights tables for a reconciliation of Non-GAAP financial measures to the most directly comparable |
| ||||||||
Twelve Months Ended | ||||||||
2022 | % | 2021 | % | |||||
Revenue | 100.0 % | 100.0 % | ||||||
Operating expenses (1) | 1,188,612 | 84.2 | 945,635 | 85.6 | ||||
Gross margin | 223,367 | 15.8 | 159,290 | 14.4 | ||||
Corporate general and administrative expenses (1) | 55,023 | 3.8 | 56,150 | 5.1 | ||||
Legal settlement, net | — | — | 30,468 | 2.7 | ||||
Operating income | 168,344 | 12.0 | 72,672 | 6.6 | ||||
Other income (expense): | ||||||||
Interest expense | (8,039) | (0.6) | (3,868) | (0.4) | ||||
Gain on sale of operations, net | 413 | — | 5,995 | 0.5 | ||||
Other (expense) income, net (1) (2) | (19,225) | (1.4) | 18,241 | 1.7 | ||||
Total other (expense) income, net | (26,851) | (2.0) | 20,368 | 1.8 | ||||
Income from continuing operations before income tax expense | 141,493 | 10.0 | 93,040 | 8.4 | ||||
Income tax expense | 36,121 | 22,129 | ||||||
Income from continuing operations | 105,372 | 7.5 | 70,911 | 6.4 | ||||
Loss from operations of discontinued businesses, net of tax | (18) | (24) | ||||||
Net income | $ 105,354 | 7.5 % | $ 70,887 | 6.4 % | ||||
Diluted income per share: | ||||||||
Continuing operations | $ 2.01 | $ 1.32 | ||||||
Discontinued operations | — | — | ||||||
Net income | $ 2.01 | $ 1.32 | ||||||
Diluted weighted average common shares outstanding | 52,388 | 53,723 | ||||||
Other data from continuing operations: | ||||||||
Adjusted EBITDA (3) | $ 190,143 | $ 148,459 | ||||||
Adjusted EPS (3) | $ 2.13 | $ 1.66 |
(1) | CBIZ sponsors a deferred compensation plan, under which a CBIZ employee's compensation deferral is held in a rabbi trust and | ||||||||||||||||||||||
Income and expenses related to the deferred compensation plan for the twelve months ended | |||||||||||||||||||||||
Twelve Months Ended | |||||||||||||||||||||||
2022 | % of Revenue | 2021 | % of Revenue | ||||||||||||||||||||
Operating (income) expenses | $ (17,252) | (1.2) % | $ 17,317 | 1.6 % | |||||||||||||||||||
Corporate general and administrative (income) expenses | (2,393) | (0.2) % | 2,168 | 0.2 % | |||||||||||||||||||
Other (expense) income, net | (19,645) | (1.4) % | 19,485 | 1.8 % | |||||||||||||||||||
Excluding the impact of the above-mentioned income and expenses related to the deferred compensation plan, the operating | |||||||||||||||||||||||
Twelve Months Ended | |||||||||||||||||||||||
2022 | 2021 | ||||||||||||||||||||||
As | Deferred | Adjusted | % of | As | Deferred | Adjusted | % of | ||||||||||||||||
Gross margin | $ (17,252) | 14.6 % | $ 17,317 | 16.0 % | |||||||||||||||||||
Operating income | 168,344 | (19,645) | 148,699 | 10.5 % | 72,672 | 19,485 | 92,157 | 8.3 % | |||||||||||||||
Other (expense) income, net | (19,225) | 19,645 | 420 | — % | 18,241 | (19,485) | (1,244) | (0.1) % | |||||||||||||||
Income from continuing operations | 141,493 | — | 141,493 | 10.0 % | 93,040 | — | 93,040 | 8.4 % | |||||||||||||||
(2) | Included in "Other (expense) income, net" for the twelve months ended | ||||||||||||||||||||||
(3) | Refer to the financial highlights tables for a reconciliation of Non-GAAP financial measures to the most directly comparable |
| ||||||||
SELECT SEGMENT DATA | ||||||||
Three Months Ended December | Twelve Months Ended December | |||||||
2022 | 2021 | 2022 | 2021 | |||||
Revenue | ||||||||
Financial Services | $ 202,016 | $ 156,056 | 1,010,068 | 734,026 | ||||
Benefits and Insurance Services | 81,746 | 76,667 | 358,007 | 332,323 | ||||
National Practices | 11,281 | 10,105 | 43,904 | 38,576 | ||||
Total | $ 295,043 | $ 242,828 | $ 1,411,979 | $ 1,104,925 | ||||
Gross Margin | ||||||||
Financial Services (1) | (8,242) | (3,338) | $ 160,030 | $ 125,788 | ||||
Benefits and Insurance Services | 12,357 | 8,765 | 67,620 | 60,673 | ||||
National Practices | 1,298 | 1,153 | 4,703 | 4,082 | ||||
Operating expenses - unallocated (2): | ||||||||
Other expense | (7,182) | (4,002) | (26,238) | (13,936) | ||||
Deferred compensation | (5,748) | (6,152) | 17,252 | (17,317) | ||||
Total | $ (7,517) | $ (3,574) | $ 223,367 | $ 159,290 |
(1) | Gross margin for the Financial Services practice group included approximately |
(2) | Represents operating expenses not directly allocated to individual businesses, including stock-based compensation, consolidation and integration charges, and certain advertising expenses. "Operating expenses - unallocated" also includes gains or losses attributable to the assets held in a rabbi trust associated with the Company's deferred compensation plan. These gains or losses do not impact "Income from continuing operations before income tax expense" as they are directly offset by the same adjustment to "Other income, net" in the Consolidated Statements of Comprehensive Income. Net gains/losses recognized from adjustments to the fair value of the assets held in the rabbi trust are recorded as compensation expense in "Operating expenses" and "Corporate, general and administrative expenses," and offset in "Other income, net." |
| ||||
Twelve Months Ended | ||||
2022 | 2021 | |||
Net income | $ 105,354 | $ 70,887 | ||
Adjustments to reconcile net income to net cash provided by operating activities: | ||||
Depreciation and amortization expense | 32,895 | 27,078 | ||
Gain on sale of operations, net | (413) | (5,995) | ||
Bad debt expense, net of recoveries | 1,173 | 3,054 | ||
Adjustments to contingent earnout liability, net | 2,435 | 2,367 | ||
Stock-based compensation expense | 14,689 | 11,407 | ||
Other noncash adjustments | 12,060 | 9,108 | ||
Net income, after adjustments to reconcile net income to net cash provided by | 168,193 | 117,906 | ||
Changes in assets and liabilities, net of acquisitions and divestitures | (42,043) | 13,272 | ||
Operating cash flows provided by continuing operations | 126,150 | 131,178 | ||
Operating cash used in discontinued operations | (18) | (24) | ||
Net cash provided by operating activities | 126,132 | 131,154 | ||
Net cash used in investing activities | (99,118) | (82,010) | ||
Net cash used in financing activities | (17,343) | (69,005) | ||
Net increase (decrease) in cash, cash equivalents and restricted cash | 9,671 | (19,861) | ||
Cash, cash equivalents and restricted cash at beginning of year | $ 150,474 | $ 170,335 | ||
Cash, cash equivalents and restricted cash at end of period | $ 160,145 | $ 150,474 | ||
Reconciliation of cash, cash equivalents and restricted cash to the | ||||
Cash and cash equivalents | $ 4,697 | $ 1,997 | ||
Restricted cash | 28,487 | 30,383 | ||
Cash equivalents included in funds held for clients | 126,961 | 118,094 | ||
Total cash, cash equivalents and restricted cash | $ 160,145 | $ 150,474 |
| ||||
Cash and cash equivalents | 4,697 | 1,997 | ||
Restricted cash | 28,487 | 30,383 | ||
Accounts receivable, net | 334,498 | 242,168 | ||
Current assets before funds held for clients | 397,113 | 293,765 | ||
Funds held for clients | 171,313 | 157,909 | ||
951,702 | 840,783 | |||
Total assets | 1,879,124 | 1,627,934 | ||
Current liabilities before client fund obligations | 338,940 | 265,174 | ||
Client fund obligations | 173,467 | 158,115 | ||
Total long-term debt | 263,654 | 154,851 | ||
Total liabilities | 1,165,672 | 923,386 | ||
(824,778) | (694,716) | |||
Total stockholders' equity | 713,452 | 704,548 | ||
Debt to equity | 37.0 % | 22.0 % | ||
Days sales outstanding (DSO) - continuing operations (1) | 74 | 71 | ||
Shares outstanding | 50,180 | 52,038 | ||
Basic weighted average common shares outstanding | 51,502 | 52,637 | ||
Diluted weighted average common shares outstanding | 52,388 | 53,723 |
(1) | DSO is provided for continuing operations and represents accounts receivable, net, at the end of the period, divided by trailing twelve-month daily revenue. The Company has included DSO data because such data is commonly used as a performance measure by analysts and investors and as a measure of the Company's ability to collect on receivables in a timely manner. DSO should not be regarded as an alternative or replacement to any measurement of performance under GAAP. |
| |||||||
Three Months Ended December | Twelve Months Ended December | ||||||
2022 | 2021 | 2022 | 2021 | ||||
(Loss) Income from continuing operations | $ (11,493) | $ (9,613) | $ 105,372 | $ 70,911 | |||
Interest expense | 2,830 | 1,016 | 8,039 | 3,868 | |||
Income tax (benefit) expense | (4,953) | (3,971) | 36,121 | 22,129 | |||
(Gain) loss on sale of operations, net | (102) | 390 | (413) | (5,995) | |||
Gain on sale of assets, net (2) | — | — | (2,391) | — | |||
Legal settlement, net | — | — | — | 30,468 | |||
Transaction costs related to | — | — | 1,329 | — | |||
Integration and retention costs related to | 1,179 | — | 9,191 | — | |||
Depreciation | 2,853 | 2,771 | 11,231 | 10,781 | |||
Amortization | 5,335 | 4,386 | 21,664 | 16,297 | |||
Adjusted EBITDA | $ (4,351) | $ (5,021) | $ 190,143 | $ 148,459 |
(1) | CBIZ reports its financial results in accordance with GAAP. This table reconciles Adjusted EBITDA to the most directly comparable GAAP financial measure, "(Loss) Income from continuing operations." Adjusted EBITDA is not defined by GAAP and should not be regarded as an alternative or replacement to any measurement of performance under GAAP. Adjusted EBITDA is commonly used by the Company, its shareholders and debt holders as a performance measurement to evaluate, assess and benchmark the Company's operational results. |
(2) | This gain is related to a sale of a book of business in CBIZ's property and casualty line of service, and is recorded in Other income (expense), net. |
(3) | These costs include, but are not limited to, certain consulting, technology, personnel, as well as other first year operating and general administrative costs that are non-recurring in nature. |
| |||||||
Three Months Ended December |
Three Months Ended | ||||||
Amounts | EPS | Amounts | EPS | ||||
Loss from continuing operations | $ (11,493) | $ (0.23) | $ (9,613) | $ (0.19) | |||
Adjustments: | |||||||
Integration and retention costs related to | 1,179 | 0.02 | — | — | |||
Income tax effect related to adjustments | (355) | — | — | — | |||
Adjusted loss from continuing operations | $ (10,669) | $ (0.21) | $ (9,613) | $ (0.19) |
Twelve Months Ended December |
Twelve Months Ended | ||||||
Amounts | EPS | Amounts | EPS | ||||
Income from continuing operations | $ 105,372 | $ 2.01 | $ 70,911 | $ 1.32 | |||
Adjustments: | |||||||
Gain on sale of operations, net (2) | — | — | (6,311) | (0.12) | |||
Gain on sale of assets, net (3) | (2,391) | (0.05) | — | — | |||
Legal settlement, net | — | — | 30,468 | 0.57 | |||
Transaction costs related to | 1,329 | 0.03 | — | — | |||
Integration and retention costs related to | 9,191 | 0.18 | — | — | |||
Income tax effect related to adjustments | (2,075) | (0.04) | (5,746) | (0.11) | |||
Adjusted income from continuing operations | $ 111,426 | $ 2.13 | $ 89,322 | $ 1.66 |
(1) | CBIZ reports its financial results in accordance with GAAP. This table reconciles Adjusted (Loss) Income and Adjusted EPS to the most directly comparable GAAP financial measures, "(Loss) Income from continuing operations" and "Diluted earnings per share from continuing operations." Adjusted (Loss) Income and Adjusted EPS are not defined by GAAP and should not be regarded as an alternative or replacement to any measurement of performance under GAAP. Adjusted (Loss) Income and Adjusted EPS, are used by the Company for its shareholders and debt holders as a performance measure to evaluate, assess and benchmark the Company's operational results. |
(2) | This gain related to a one-time non-recurring gain from the sale of an operation in CBIZ's Benefit and Insurance Services practice group. |
(3) | This gain is related to a sale of a book of business in CBIZ's property and casualty line of service, and is recorded in Other income (expense), net. |
(4) | These costs include, but are not limited to, certain consulting, technology, personnel, as well as other first year operating and general administrative costs that are non-recurring in nature. |
| |||
Full Year 2023 Guidance | |||
Low | High | ||
Diluted EPS - GAAP Guidance | $ 2.31 | $ 2.36 | |
Integration cost related to | 0.05 | 0.05 | |
Adjusted Diluted EPS Guidance | $ 2.36 | $ 2.41 | |
GAAP Diluted EPS for 2022 | $ 2.01 | $ 2.01 | |
Adjusted Diluted EPS for 2022 | $ 2.13 | $ 2.13 | |
15 % | 17 % | ||
11 % | 13 % |
View original content:https://www.prnewswire.com/news-releases/cbiz-reports-fourth-quarter-and-full-year-2022-results-301748206.html
SOURCE
FAQ
What were CBIZ's fourth-quarter revenue results for 2022?
What is the outlook for CBIZ in 2023?
What were CBIZ's full-year revenue results for 2022?
What was the GAAP EPS for CBIZ in 2022?